Why is qin shi huang famous

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: While the BCG vaccine offers significant protection against severe forms of tuberculosis (TB), particularly in children, it does not provide complete immunity. Therefore, vaccinated individuals can still contract TB, though the illness is often less severe and less likely to be fatal. The effectiveness of the vaccine can vary, and reinfection is possible, especially with exposure to highly contagious strains or in individuals with weakened immune systems.

Key Facts

The BCG vaccine is primarily effective against disseminated TB in children, reducing mortality rates.
BCG vaccination offers variable protection against pulmonary TB in adults, with some studies showing limited efficacy.
The duration of protection from BCG vaccination can wane over time, potentially leaving individuals more susceptible to infection later in life.
Factors such as geographic location, the specific TB strain encountered, and individual immune status can influence the risk of infection after vaccination.
Even if infected, vaccinated individuals are less likely to develop severe disease, hospitalization, or death from TB compared to unvaccinated individuals.

Overview

Tuberculosis (TB) remains a significant global health challenge, caused by the bacterium Mycobacterium tuberculosis. While advancements in treatment and public health measures have reduced its incidence in many parts of the world, TB continues to affect millions annually. Vaccination is a key tool in the fight against infectious diseases, and for TB, the primary vaccine used globally is the Bacillus Calmette-Guérin (BCG) vaccine. However, a common question arises: can individuals who have received the BCG vaccine still contract tuberculosis? The answer is nuanced, as the vaccine's protection is not absolute.

The BCG vaccine has been in use for nearly a century and is particularly effective in preventing severe, disseminated forms of TB in infants and young children, such as tuberculous meningitis and miliary TB, which can be fatal. Its impact on preventing pulmonary TB, the most common form of the disease in adults, is more variable and has been a subject of extensive research. Understanding the limitations and benefits of BCG vaccination is crucial for appreciating the risk of TB infection in vaccinated individuals.

How It Works

BCG Vaccine Mechanism: The BCG vaccine is a live-attenuated strain of Mycobacterium bovis, a bacterium closely related to the one that causes human TB. When administered, it stimulates the immune system to develop a response against Mycobacterium tuberculosis. This immune response aims to prepare the body to fight off future infections, primarily by activating T-cells and other immune components that can target and eliminate the bacteria.
Protection Against Severe Disease: The most well-established benefit of the BCG vaccine is its ability to protect young children from the most severe and life-threatening forms of TB. Studies have consistently shown a high degree of efficacy in preventing tuberculous meningitis and miliary TB in this age group, thereby significantly reducing mortality.
Variable Efficacy Against Pulmonary TB: The protection offered by BCG against pulmonary TB in adults is less consistent and can vary widely depending on geographical location and the circulating strains of TB. Some studies show moderate protection, while others indicate very little to no significant protective effect against adult pulmonary TB. This variability is thought to be influenced by factors such as the genetic diversity of TB strains, environmental mycobacteria exposure, and differences in vaccine administration or preparation.
Waning Immunity and Reinfection: The immunity conferred by the BCG vaccine can decrease over time, a phenomenon known as waning immunity. This means that protection may be stronger in the years following vaccination and gradually diminish as an individual gets older. Consequently, a vaccinated adult may become more susceptible to TB infection, especially if they have prolonged or intense exposure to the bacteria.

Key Comparisons

Feature	BCG Vaccination	Untreated TB Infection
Risk of Severe TB in Children	Significantly Reduced	High
Risk of Pulmonary TB in Adults	Variable, Can Still Occur	High
Immune Response	Stimulates immunity against TB	Active infection overwhelms the immune system
Prevention of All TB Forms	Not 100% effective	N/A (this is the disease itself)

Why It Matters

Impact on Global TB Burden: Despite its limitations, BCG vaccination remains a critical public health intervention, particularly in countries with a high incidence of childhood TB. It is estimated to prevent tens of thousands of deaths from TB in children each year, contributing significantly to the global effort to control the disease.
Continued Risk of Infection: The fact that BCG vaccination does not confer complete immunity means that vaccinated individuals can still become infected with TB. This underscores the importance of continued TB prevention strategies, including prompt diagnosis, effective treatment, and public health measures aimed at reducing transmission, even in vaccinated populations.
Importance of Research: The variability in BCG vaccine efficacy highlights the ongoing need for research into more effective TB vaccines. Scientists are exploring new vaccine candidates and strategies that could offer broader and more durable protection against all forms of TB, especially in adults, which would be a monumental step forward in eradicating this ancient disease.

In conclusion, while the BCG vaccine provides valuable protection, especially against severe TB in children, it is not a foolproof shield against all forms of the disease. Vaccinated individuals can still contract TB, and thus, continued vigilance, preventative measures, and ongoing research into improved vaccines remain paramount in the global fight against tuberculosis.